| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |